Occidental Petroleum Corporation vs Recursion Pharmaceuticals Inc — how do they compare? Occidental Petroleum Corporation trades at $57.8 (market cap $56.20B), while Recursion Pharmaceuticals Inc trades at $2.99 (market cap $1.63B). The key difference: Occidental Petroleum Corporation is far larger — about 34.5× Recursion Pharmaceuticals Inc's market cap, and Occidental Petroleum Corporation pays a 1.84% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| OXY | RXRX | |
|---|---|---|
Market Cap | $56.20B | $1.63B |
Sector | Energy | Health |
52-Week High | $66.24 | $6.79 |
52-Week Low | $38.92 | $2.84 |
Enterprise Value | $77.28B | $1.05B |
Dividend Yield | 1.84% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Recursion Pharmaceuticals (RXRX) trades at $2.89, down 1.87% with a bearish technical signal despite recent earnings beats. The company shows significant revenue growth challenges with 2025 revenue of $74.26M but massive losses of -$644.76M, resulting in a -851.51% net margin. Analyst sentiment is mixed with 40% buy ratings but a consensus price target of $7.83, representing 171% upside potential from current levels.
While RXRX offers substantial upside based on analyst targets, the stock carries high risk due to persistent losses, negative cash flow from operations, and unproven AI-driven drug discovery platform. The company's heavy reliance on financing activities to fund operations presents ongoing dilution risk, making this suitable only for risk-tolerant investors betting on long-term biotech breakthroughs.
Trailing returns across standard periods
Latest headlines on both assets
Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2021, the company reported net proved reserves of 3.5 billion barrels of oil equivalent. Net production averaged 1,174 thousand barrels of oil equivalent per day in 2021 at a ratio of 75% oil and natural gas liquids and 25% natural gas.
Read more on OXY →Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →